2 October 2026 · MHRA
MHRA guidance covers changes to medicines marketing authorisations
Medical businessesRegulation & claims
The MHRA guidance covers applications to change a medicine’s marketing authorisation. It includes minor variations of types IA and IB, major variations of type II, and extensions.
Why it matters
These application categories are relevant to regulatory teams managing changes to authorised medicines.
Protect your practice
Summary for general information only — not legal, clinical or insurance advice.